Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

Daniel Grint; Lars Peters; Juergen K Rockstroh; Stephane de Wit; Victor M Mitsura; Brygida Knysz; Court Pedersen; Ole Kirk; Jens D Lundgren; Amanda Mocroft; EuroSIDA in EuroCoord

doi:10.1097/QAD.0000000000000069

Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

Daniel Grint, Lars Peters, Juergen K Rockstroh, Stephane de Wit, Victor M Mitsura, Brygida Knysz, Court Pedersen, Ole Kirk, Jens D Lundgren, Amanda Mocroft, EuroSIDA in EuroCoord

Department of Clinical Medicine

Research output: Contribution to journal › Journal article › Research › peer-review

11 Citations (Scopus)

Abstract

Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.

Original language	English
Journal	AIDS (London, England)
Volume	28
Issue number	4
Pages (from-to)	577-587
Number of pages	11
DOIs	https://doi.org/10.1097/QAD.0000000000000069
Publication status	Published - 20 Feb 2014

Access to Document

10.1097/QAD.0000000000000069

Cite this

Grint, D., Peters, L., Rockstroh, J. K., de Wit, S., Mitsura, V. M., Knysz, B., Pedersen, C., Kirk, O., Lundgren, J. D., Mocroft, A., & EuroSIDA in EuroCoord (2014). Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis. AIDS (London, England), 28(4), 577-587. https://doi.org/10.1097/QAD.0000000000000069

Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis. / Grint, Daniel; Peters, Lars; Rockstroh, Juergen K; de Wit, Stephane; Mitsura, Victor M; Knysz, Brygida; Pedersen, Court; Kirk, Ole ; Lundgren, Jens D; Mocroft, Amanda; EuroSIDA in EuroCoord.

In: AIDS (London, England), Vol. 28, No. 4, 20.02.2014, p. 577-587.

Research output: Contribution to journal › Journal article › Research › peer-review

Grint, D, Peters, L, Rockstroh, JK, de Wit, S, Mitsura, VM, Knysz, B, Pedersen, C, Kirk, O , Lundgren, JD, Mocroft, A & EuroSIDA in EuroCoord 2014, 'Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis', AIDS (London, England), vol. 28, no. 4, pp. 577-587. https://doi.org/10.1097/QAD.0000000000000069

Grint, Daniel ; Peters, Lars ; Rockstroh, Juergen K ; de Wit, Stephane ; Mitsura, Victor M ; Knysz, Brygida ; Pedersen, Court ; Kirk, Ole ; Lundgren, Jens D ; Mocroft, Amanda ; EuroSIDA in EuroCoord. / Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis. In: AIDS (London, England). 2014 ; Vol. 28, No. 4. pp. 577-587.

@article{8aba921d26a04699b2e918271da8324f,

title = "Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis",

abstract = "Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.",

author = "Daniel Grint and Lars Peters and Rockstroh, {Juergen K} and {de Wit}, Stephane and Mitsura, {Victor M} and Brygida Knysz and Court Pedersen and Ole Kirk and Lundgren, {Jens D} and Amanda Mocroft and {EuroSIDA in EuroCoord}",

year = "2014",

month = feb,

day = "20",

doi = "10.1097/QAD.0000000000000069",

language = "English",

volume = "28",

pages = "577--587",

journal = "AIDS",

issn = "1350-2840",

publisher = "Lippincott Williams & Wilkins, Ltd.",

number = "4",

}

TY - JOUR

T1 - Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

AU - Grint, Daniel

AU - Peters, Lars

AU - Rockstroh, Juergen K

AU - de Wit, Stephane

AU - Mitsura, Victor M

AU - Knysz, Brygida

AU - Pedersen, Court

AU - Kirk, Ole

AU - Lundgren, Jens D

AU - Mocroft, Amanda

AU - EuroSIDA in EuroCoord

PY - 2014/2/20

Y1 - 2014/2/20

N2 - Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.

AB - Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.

U2 - 10.1097/QAD.0000000000000069

DO - 10.1097/QAD.0000000000000069

M3 - Journal article

C2 - 24468998

VL - 28

SP - 577

EP - 587

JO - AIDS

JF - AIDS

SN - 1350-2840

IS - 4

ER -